pentobarbital will reduce the level or outcome of linagliptin by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Monitor. Use of different treatment options is strongly advisable when linagliptin should be to be administered by using a CYP3A4 inducerpentobarbital will lower the extent or influence of cilostazol by affecting hepat